269 related articles for article (PubMed ID: 11693329)
1. Intestinal permeability is increased in a proportion of spouses of patients with Crohn's disease.
Breslin NP; Nash C; Hilsden RJ; Hershfield NB; Price LM; Meddings JB; Sutherland LR
Am J Gastroenterol; 2001 Oct; 96(10):2934-8. PubMed ID: 11693329
[TBL] [Abstract][Full Text] [Related]
2. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease.
D'Incà R; Annese V; di Leo V; Latiano A; Quaino V; Abazia C; Vettorato MG; Sturniolo GC
Aliment Pharmacol Ther; 2006 May; 23(10):1455-61. PubMed ID: 16669960
[TBL] [Abstract][Full Text] [Related]
3. Increased gastric and intestinal permeability in patients with Crohn's disease.
Wyatt J; Oberhuber G; Pongratz S; Püspök A; Moser G; Novacek G; Lochs H; Vogelsang H
Am J Gastroenterol; 1997 Oct; 92(10):1891-6. PubMed ID: 9382060
[TBL] [Abstract][Full Text] [Related]
4. [Intestinal permeability in relatives of patients with Crohn's disease].
Kohout P; Koref P
Vnitr Lek; 2001 Jun; 47(6):371-4. PubMed ID: 11494882
[TBL] [Abstract][Full Text] [Related]
5. Genetic aspects of intestinal permeability in inflammatory bowel disease.
Takeuchi K; Maiden L; Bjarnason I
Novartis Found Symp; 2004; 263():151-8; discussion 159-63, 211-8. PubMed ID: 15669640
[TBL] [Abstract][Full Text] [Related]
6. Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: an inherited defect in mucosal defence?
Söderholm JD; Olaison G; Lindberg E; Hannestad U; Vindels A; Tysk C; Järnerot G; Sjödahl R
Gut; 1999 Jan; 44(1):96-100. PubMed ID: 9862833
[TBL] [Abstract][Full Text] [Related]
7. Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn's disease in Southern Italy.
Fries W; Renda MC; Lo Presti MA; Raso A; Orlando A; Oliva L; Giofré MR; Maggio A; Mattaliano A; Macaluso A; Cottone M
Am J Gastroenterol; 2005 Dec; 100(12):2730-6. PubMed ID: 16393227
[TBL] [Abstract][Full Text] [Related]
8. Bowel permeability and CD45RO expression on circulating CD20+ B cells in patients with ankylosing spondylitis and their relatives.
Vaile JH; Meddings JB; Yacyshyn BR; Russell AS; Maksymowych WP
J Rheumatol; 1999 Jan; 26(1):128-35. PubMed ID: 9918253
[TBL] [Abstract][Full Text] [Related]
9. Effect of moderate exercise on Crohn's disease patients in remission.
D'Incà R; Varnier M; Mestriner C; Martines D; D'Odorico A; Sturniolo GC
Ital J Gastroenterol Hepatol; 1999 Apr; 31(3):205-10. PubMed ID: 10379481
[TBL] [Abstract][Full Text] [Related]
10. Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation?
Buhner S; Buning C; Genschel J; Kling K; Herrmann D; Dignass A; Kuechler I; Krueger S; Schmidt HH; Lochs H
Gut; 2006 Mar; 55(3):342-7. PubMed ID: 16000642
[TBL] [Abstract][Full Text] [Related]
11. Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission.
Garcia Vilela E; De Lourdes De Abreu Ferrari M; Oswaldo Da Gama Torres H; Guerra Pinto A; Carolina Carneiro Aguirre A; Paiva Martins F; Marcos Andrade Goulart E; Sales Da Cunha A
Scand J Gastroenterol; 2008; 43(7):842-8. PubMed ID: 18584523
[TBL] [Abstract][Full Text] [Related]
12. Passage of molecules through the wall of the gastrointestinal tract. Intestinal permeability to polyethyleneglycol 1 000 in patients with Crohn's disease.
Heuman R; Sjödahl R; Tagesson C
Acta Chir Scand; 1982; 148(3):281-4. PubMed ID: 7136430
[TBL] [Abstract][Full Text] [Related]
13. Altered intestinal permeability to low-molecular-weight polyethyleneglycols (PEG 400) in patients with Crohn's disease.
Magnusson KE; Sundqvist T; Sjödahl R; Tagesson C
Acta Chir Scand; 1983; 149(3):323-7. PubMed ID: 6613469
[TBL] [Abstract][Full Text] [Related]
14. Intestinal permeability in patients with Crohn's disease and their first-degree relatives.
Howden CW; Gillanders I; Morris AJ; Duncan A; Danesh B; Russell RI
Am J Gastroenterol; 1994 Aug; 89(8):1175-6. PubMed ID: 8053430
[TBL] [Abstract][Full Text] [Related]
15. Increased intestinal permeability in patients with inflammatory bowel disease.
Welcker K; Martin A; Kölle P; Siebeck M; Gross M
Eur J Med Res; 2004 Oct; 9(10):456-60. PubMed ID: 15546811
[TBL] [Abstract][Full Text] [Related]
16. Clinical response does not correlate with intestinal or blood cyclosporine concentrations in patients with Crohn's disease treated with high-dose oral cyclosporine.
Sandborn WJ; Tremaine WJ; Lawson GM
Am J Gastroenterol; 1996 Jan; 91(1):37-43. PubMed ID: 8561141
[TBL] [Abstract][Full Text] [Related]
17. Intestinal permeability test as a predictor of clinical course in Crohn's disease.
D'Incà R; Di Leo V; Corrao G; Martines D; D'Odorico A; Mestriner C; Venturi C; Longo G; Sturniolo GC
Am J Gastroenterol; 1999 Oct; 94(10):2956-60. PubMed ID: 10520851
[TBL] [Abstract][Full Text] [Related]
18. Skeletal muscle wastage in Crohn's disease: a pathway shared with heart failure?
Cuoco L; Vescovo G; Castaman R; Ravara B; Cammarota G; Angelini A; Salvagnini M; Dalla Libera L
Int J Cardiol; 2008 Jul; 127(2):219-27. PubMed ID: 17692969
[TBL] [Abstract][Full Text] [Related]
19. Anti-TNF-α antibodies improve intestinal barrier function in Crohn's disease.
Noth R; Stüber E; Häsler R; Nikolaus S; Kühbacher T; Hampe J; Bewig B; Schreiber S; Arlt A
J Crohns Colitis; 2012 May; 6(4):464-9. PubMed ID: 22398062
[TBL] [Abstract][Full Text] [Related]
20. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M
Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
